247 Consolidation and Worsening Patient Experience in Third Party IVF. Eloise Drane
Everyone wants to grow their third party IVF program, but are we neglecting patient experience in the process?This week on Inside Reproductive Health, Eloise Drane, 3 time gestational carrier, MBA, and founder of Family Inceptions, shares her honest take on how responsiveness and individualized care have declined, even as demand has stabilized post-2021.Drawing from 17 years of experience running her own surrogacy agency, Eloise offers a kind but direct update on:Why patient experience is harder than ever to deliver (and how to improve it)How consolidation impacts intended parents and surrogacy wait timesThe challenges of startups and in-house agency models in IVF networksWhat she’s looking for in a surrogacy agency before considering merging or acquiringWhy the “same workflows” just won’t cut it for gestational carrier cyclesIf your practice or network is looking to scale GC IVF—and actually retain intended parents—this is a must-listen.
--------
46:31
246 M&A Strategies For Small Fertility Practices, Before It's Too Late. Dr. Brijinder Minhas, Robert Goodman, Richard Groberg.
What’s your exit strategy?For single providers and small fertility practice owners, the difference between a multimillion-dollar sale and walking away with nothing often comes down to timing and preparation.This week on Inside Reproductive Health, I sit down with Bob Goodman, Richard Groberg, and Dr. Brijinder Minhas of MidCap Advisors to discuss:The current state of fertility clinic mergers & acquisitionsWhy many fertility MSOs are preparing to sell their networksWhen it’s too late to maximize your practice’s valueHow selling with a competitor could radically increase your exit priceThe biggest risks that lower your practice’s valuationIf you think you might sell your practice in the next 10-15 years, now is the time to start planning. MidCap’s team works with clinic owners to increase their valuation and secure the best possible deal—and they don’t charge fees unless you get paid.Don’t leave money on the table. Listen now to learn how to secure your financial future.
--------
43:58
245 Barriers to Scaling Third Party IVF. A Call For Guidelines In Genetic Testing. Dr. Mili Thakur
Genetics is nobody’s baby—or at least this week’s guest seems to think so.Dr. Mili Thakur, an REI, geneticist, and consultant through Genome Ally, joins us to break down the gaps in genetic testing, the impact on patient care, and why ASRM and others must step up to set industry-wide standards.Tune in to hear:The risks inconsistent genetic testing poses to patients and clinics.How the lack of standardization creates unnecessary workflow burdens.Why genetic discrepancies hurt patient retention and third-party treatment conversion.The missing tools needed to improve third-party IVF programs.Dr. Thakur’s call to action for genetics companies to step up and lead the charge.
--------
55:01
244 The IVF Orchestra: Winners & Losers In the Patient-Driven Marketplace. Dr. Cristina Hickman
Who’s adding the most value in IVF today—and who might not be here tomorrow?This week on Inside Reproductive Health, Dr. Cristina Hickman, founder of Avenue Center for Reproductive Medicine in London, breaks down the fertility field’s evolving landscape. As a PhD embryologist and clinic owner, she shares her perspective on industry leaders, automation, and the shifting role of technology in fertility care.Tune in to learn:Why some clinic networks might be overextending by bringing too many verticals in-house.How automation could scale embryologist efficiency to 2,000+ cycles per year.The surprising relationship between robotics and AI in embryology.Which companies are providing the most value right now--in lab automation, EMR, financial management, and cryo storage and moreHow new intelligence could challenge the current standard of single embryo transfer.Listen now to hear Dr. Hickman’s take on where the field is headed—and who’s leading the way.
--------
54:35
243 30% Egg Freezing Retrievals & Brazil's First PE Owned Fertility Clinic Network. Dr. Marcus Dantas Martins
What if 30% of your fertility clinic’s egg retrievals were for egg freezing?That’s the reality at FertGroup in Brazil, where Dr. Marcus Dantas Martins, Chief Operating Officer, is leading a transformative approach to fertility care. In this episode, Dr. Dantas reveals how Fert Group is leveraging technology and private equity to expand their influence in the rapidly growing Brazilian market.Join us as Dr. Dantas discusses:The Rise of Egg Freezing (And how the trend is reshaping fertility care in Brazil)How Private Equity has shaped their rapid expansionFertGroup’s Impact on patient outcomes (And its implications in the broader fertility landscape)How FertGroup is making egg freezing more accessible across Brazil.Why they bought >50% of the embryoscopes in Brazil to make it happenTune in to hear more about the future of fertility care in Latin America and how private equity is shaping the industry.
Inside Reproductive Health is your source for information about the growing field of fertility. Inside Reproductive Health features an active blog and weekly interviews with leaders from the clinical, investment, patient relations, and pharmaceutical corners of reproductive medicine. Be sure to subscribe to our podcast and check back frequently for new content!
Brasil